PERFORMANCE OF DRAFT 2022 ACR/EULAR CLASSIFICATION CRITERIA IN A TURKISH COHORT OF APL ANTIBODY POSITIVE PATIENTS

被引：0

作者：

Kardas, R. C. ^{[1
]}

Yildirim, D. ^{[1
]}

Ozkiziltas, B. ^{[1
]}

Vasi, I. ^{[1
]}

Duran, R. ^{[1
]}

Karadeniz, H. ^{[1
]}

Guler, A. Avanoglu ^{[1
]}

Erden, A. ^{[1
]}

Kucuk, H. ^{[1
]}

Goker, B. ^{[1
]}

Tufan, A. ^{[1
]}

Ozturk, M. A. ^{[1
]}

机构：

[1] Gazi Univ, Div Rheumatol, Dept Med, Ankara, Turkiye

来源：

ANNALS OF THE RHEUMATIC DISEASES | 2023年 / 82卷

关键词：

Epidemiology; Anti-phospholipid syndrome; Autoantibodies;

D O I：

10.1136/annrheumdis-2023-eular.6333

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

AB0701

引用

页码：1554 / 1554

页数：1

共 3 条

[1]

Jarrett K., 2022, INVESTIGATORS UNVEIL

[2] International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS) [J].

Miyakis, S ;

Lockshin, MD ;

Atsumi, T ;

Branch, DW ;

Brey, RL ;

Cervera, R ;

Derksen, RHWM ;

De Groot, PG ;

Koike, T ;

Meroni, PL ;

Reber, G ;

Shoenfeld, Y ;

Tincani, A ;

Vlachoyiannopoulos, PG ;

Krilis, SA .

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2006, 4 (02) :295-306

[3]

Ugolini-Lopes MR, 2017, ANTIPHOSPHOLIPID SYN, P247, DOI [10.1007/978-3-319-55442-6_13, DOI 10.1007/978-3-319-55442-6_13]

← 1 →